Adicet Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Adicet Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Adicet Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $99.1M, a 10.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $99.1M +$9.58M +10.7% Dec 31, 2023 10-K 2024-03-19
Q4 2022 $89.5M +$16.3M +22.3% Dec 31, 2022 10-K 2024-03-19
Q4 2021 $73.2M +$15.4M +26.8% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $57.7M +$37.9M +191% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $19.8M +$8.08M +68.8% Dec 31, 2019 10-K 2021-03-12
Q4 2018 $11.7M +$6.43M +121% Dec 31, 2018 10-K 2021-03-12
Q4 2017 $5.31M Dec 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.